Associate Director / Director of Statistics
- Adicet Bio, Inc.
- Redwood City, CA
- Start date
- Mar 23, 2023
- Information Technology, Business/Data Analytics, Science/R&D, Bioanalytical Services, Biostatistics
- Required Education
- Position Type
- Full time
- Biotech Bay
Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) and adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.
ASSOCIATE DIRECTOR / DIRECTOR OF STATISTICS
Adicet bio is seeking a statistician who will be responsible of leading daily activities of clinical trials. The position will provide technical expertise and experience to conduct data analyses, recommendations to statistical designs for clinical trials of all phases. The position will work collaboratively across various functions in the planning, conduct and analyses of clinical trials.
The position will report to Vice president, Biometrics.
- Author statistical analysis plan, TLF shells and table of contents for outputs to be generated.
- Perform analysis, interpret study results, and collaborate with clinical team to produce interim reports, final reports, and publications.
- Review ADaM specifications and verify key endpoints in TFLs.
- Review CRFs, CRF edit checks and CRF completion guidelines.
- Responsible for one or more studies with concurrent tasks and timelines.
- Aid in establishment of internal biostatistics processes and procedures.
- PhD degree in statistics or biostatistics
- 5+ year of statistical analysis experience in pharmaceutical or biotechnology industry (Including CRO)
- Familiar with SAS or R
- Demonstrate effective verbal and written communication skills and interpersonal skills.
- Proven ability of literature/scientific research and apply new methodology in clinical trials.
At Adicet, our people are our greatest focus. We believe that attracting and retaining the best and brightest is the key to achieving our mission to deliver best-in-class gamma delta T cell therapies for patients fighting cancer.
We offer a competitive compensation package including base salary, annual cash bonus, long-term incentives (equity), Employee Stock Purchase Plan (ESPP) and a 401(k) with ROTH and a 4.5% Company match.
To ensure the wellness of our employees and their loved ones, we offer comprehensive health plans (medical, dental, vision, etc.), Flexible Health and Commuter Spending Accounts (FSA) and a company matched Health Savings Account (HSA). We also offer a life, AD&D, short and long-term disability insurance, and legal, pet, and various other voluntary insurance programs.
We also believe our greatest ideas come when we are refreshed and focused, and we offer generous paid time-off including 12 company holidays with end-of-year shutdown, vacation, sick time, and paid parental leave.
Adicet is located in a state-of-the-art facility and works to create an incredible office experience with an onsite gym and various other fitness options, abundant, zero-cost, onsite parking with electric vehicle charging stations and free shuttle (Caltrain), company subsidized lunches (delivered onsite daily) and fully stocked breakrooms.
In compliance with California’s pay transparency law and in pursuit of pay equity and fairness, we publish salary ranges for all open positions. The pay scale range for this role is $180,000.00 - $266,000.00 annualized base salary. The salary of the finalist selected for this role will be set based on a variety of factors, including but not limited to, their qualifications (education, experience, specialty, and training), and peer and market data. This listed salary range represents the Company’s good faith and reasonable estimate of the range of possible compensation at the time of posting.
Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors. Adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and then generating T Cell Receptor-like monoclonal antibodies (TCRLs) directed to these cancer-specific peptide targets presented by MHC Class I complexes. These TCRLs are being used to arm T cells or as T cell engagers in solid tumors. In August 2016, Adicet entered into a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop next-generation engineered immune-cell therapeutics using Adicet's gamma delta T cell allogeneic platform technology.
For more information, please visit our website at http://www.adicetbio.com.
200 Constitution Drive
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.Create alert